Viral Vectors Applied for RNAi-Based Antiviral Therapy

RNA interference (RNAi) provides the means for alternative antiviral therapy. Delivery of RNAi in the form of short interfering RNA (siRNA), short hairpin RNA (shRNA) and micro-RNA (miRNA) have demonstrated efficacy in gene silencing for therapeutic applications against viral diseases. Bioinformatic...

Full description

Bibliographic Details
Main Author: Kenneth Lundstrom
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/12/9/924
_version_ 1797556192303644672
author Kenneth Lundstrom
author_facet Kenneth Lundstrom
author_sort Kenneth Lundstrom
collection DOAJ
description RNA interference (RNAi) provides the means for alternative antiviral therapy. Delivery of RNAi in the form of short interfering RNA (siRNA), short hairpin RNA (shRNA) and micro-RNA (miRNA) have demonstrated efficacy in gene silencing for therapeutic applications against viral diseases. Bioinformatics has played an important role in the design of efficient RNAi sequences targeting various pathogenic viruses. However, stability and delivery of RNAi molecules have presented serious obstacles for reaching therapeutic efficacy. For this reason, RNA modifications and formulation of nanoparticles have proven useful for non-viral delivery of RNAi molecules. On the other hand, utilization of viral vectors and particularly self-replicating RNA virus vectors can be considered as an attractive alternative. In this review, examples of antiviral therapy applying RNAi-based approaches in various animal models will be described. Due to the current coronavirus pandemic, a special emphasis will be dedicated to targeting Coronavirus Disease-19 (COVID-19).
first_indexed 2024-03-10T16:58:24Z
format Article
id doaj.art-ddbd8959fe00417395ed3c86878170d3
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-10T16:58:24Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-ddbd8959fe00417395ed3c86878170d32023-11-20T11:04:04ZengMDPI AGViruses1999-49152020-08-0112992410.3390/v12090924Viral Vectors Applied for RNAi-Based Antiviral TherapyKenneth Lundstrom0PanTherapeutics, CH1095 Lutry, SwitzerlandRNA interference (RNAi) provides the means for alternative antiviral therapy. Delivery of RNAi in the form of short interfering RNA (siRNA), short hairpin RNA (shRNA) and micro-RNA (miRNA) have demonstrated efficacy in gene silencing for therapeutic applications against viral diseases. Bioinformatics has played an important role in the design of efficient RNAi sequences targeting various pathogenic viruses. However, stability and delivery of RNAi molecules have presented serious obstacles for reaching therapeutic efficacy. For this reason, RNA modifications and formulation of nanoparticles have proven useful for non-viral delivery of RNAi molecules. On the other hand, utilization of viral vectors and particularly self-replicating RNA virus vectors can be considered as an attractive alternative. In this review, examples of antiviral therapy applying RNAi-based approaches in various animal models will be described. Due to the current coronavirus pandemic, a special emphasis will be dedicated to targeting Coronavirus Disease-19 (COVID-19).https://www.mdpi.com/1999-4915/12/9/924RNA interferenceshRNAsiRNAmiRNAgene silencingviral vectors
spellingShingle Kenneth Lundstrom
Viral Vectors Applied for RNAi-Based Antiviral Therapy
Viruses
RNA interference
shRNA
siRNA
miRNA
gene silencing
viral vectors
title Viral Vectors Applied for RNAi-Based Antiviral Therapy
title_full Viral Vectors Applied for RNAi-Based Antiviral Therapy
title_fullStr Viral Vectors Applied for RNAi-Based Antiviral Therapy
title_full_unstemmed Viral Vectors Applied for RNAi-Based Antiviral Therapy
title_short Viral Vectors Applied for RNAi-Based Antiviral Therapy
title_sort viral vectors applied for rnai based antiviral therapy
topic RNA interference
shRNA
siRNA
miRNA
gene silencing
viral vectors
url https://www.mdpi.com/1999-4915/12/9/924
work_keys_str_mv AT kennethlundstrom viralvectorsappliedforrnaibasedantiviraltherapy